|
|
||||||||
1Department of Pathology, Children's and Brigham and Women's Hospitals and Harvard Medical School, and 2Department of Medicine, Children's Hospital, Boston, Massachusetts 02115; 3Department of Pediatrics, Harbor-UCLA Research and Educational Institute, Torrance, California 90502; 4Department of Degenerative Neurological Diseases, National Institute of Neuroscience, Tokyo 187-8502; and 5Japan Society for the Promotion of Science, Tokyo 102-8471, Japan
Submitted 18 December 2002 ; accepted in final form 31 July 2003
Bombesin-peptide (BLP) immunoreactivity occurs at high levels in fetal lung. Previous studies showed that bombesin promotes fetal lung development. To test the hypothesis that such effects are mediated by known mammalian bombesin receptors [gastrin-releasing peptide (GRP)/bombesin-preferring receptor (GRPR), neuromedin B (NMB) receptor (NMBR), and the orphan bombesin receptor subtype-3 (BRS-3)], we analyzed the ontogeny of GRPR, NMBR, and BRS-3 gene expression in mouse lung. We examined the regulation of these three genes by dexamethasone and bombesin, which modulate lung development. Using incorporation of [3H]thymidine and [3H]choline, we then assessed whether GRP, NMB, and Leu8-phyllolitorin modulate lung growth and maturation in fetal lung explants. GRPR gene expression was detected predominantly in utero, whereas NMBR and BRS-3 genes were expressed from embryonic days 1316 and on multiple postnatal days. All three mRNAs are present in airway epithelium and mesenchymal cells but occur in different relative patterns. These genes were regulated differently. Dexamethasone and bombesin increased GRPR mRNA, bombesin downregulated NMBR, and neither agent affected BRS-3. GRP increased incorporation of [3H]thymidine and [3H]choline in explants, whereas NMB induced cell proliferation and Leu8-phyllolitorin yielded variable results. Cumulative data suggest the involvement of multiple BLP receptors, including novel molecules, and argue against simple functional redundancy within this gene family during lung development.
gastrin-releasing peptide; neuromedin B; bombesin receptor subtype 3; dexamethasone; cell proliferation; type II cell differentiation
This article has been cited by other articles:
![]() |
A. D. Bird, K. H. Tan, P. F. Olsson, M. Zieba, S. J. Flecknoe, D. R. Liddicoat, R. Mollard, S. B. Hooper, and T. J. Cole Identification of glucocorticoid-regulated genes that control cell proliferation during murine respiratory development J. Physiol., November 15, 2007; 585(1): 187 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shan, J. C. Aster, J. Sklar, and M. E. Sunday Notch-1 regulates pulmonary neuroendocrine cell differentiation in cell lines and in transgenic mice Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L500 - L509. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Ganter and J.-F. Pittet Bombesin-like Peptides: Modulators of Inflammation in Acute Lung Injury? Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 1 - 2. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |